Sutro Biopharma, Inc.
Prognozy (mln)
| Okres |
2024-12-31 |
2025-12-31 |
2026-12-31 |
2027-12-31 |
2028-12-31 |
2029-12-31 |
| Przychód (średnia) |
59.04 |
58.39 |
49.80 |
45.21 |
52.20 |
67.24 |
| Przychód Δ r/r |
0.00% |
-1.11% |
-14.71% |
-9.21% |
15.47% |
28.80% |
| Przychód (min) |
49.61 |
29.42 |
19.93 |
45.21 |
20.89 |
26.91 |
| Przychód (max) |
70.66 |
109.57 |
79.45 |
45.21 |
83.29 |
107.28 |
| EBITDA (średnia) |
-47.21 |
-46.68 |
-39.82 |
-36.15 |
-41.74 |
-53.76 |
| EBIT (średnia) |
-48.92 |
-48.38 |
-41.26 |
-37.46 |
-43.25 |
-55.71 |
| EBIT % |
-82.85% |
-82.85% |
-82.85% |
-82.85% |
-82.85% |
-82.85% |
| Zysk netto (średni) |
-245.22 |
-137.29 |
-99.56 |
-82.98 |
-71.93 |
-70.64 |
| Zysk netto % |
-415.32% |
-235.14% |
-199.93% |
-183.54% |
-137.78% |
-105.06% |
| EPS (średnia) |
-2.90 |
-1.79 |
-1.02 |
-0.77 |
-0.94 |
-0.92 |
| Liczba analityków (Przychody) |
9 |
8 |
9 |
6 |
2 |
5 |
| Liczba analityków (EPS) |
7 |
5 |
5 |
7 |
5 |
2 |
| symbol |
STRO |
STRO |
STRO |
STRO |
STRO |
STRO |